Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urocortin is a 40-amino acid peptide protein encoded by the UCN gene in humans and is part of the corticotropin-releasing factor (CRF) family of neuropeptides, which also includes CRF, urocortin II, and urocortin III[1]. It is widely expressed in the central and peripheral nervous systems, as well as in peripheral organs such as the heart[1][10]. Urocortin functions as an endogenous ligand for CRF receptors (particularly CRF type 1 and type 2 receptors) and is a primary ligand for the CRF type 2 receptor due to its higher binding affinity[1][8]. Urocortin regulates the stress response (including the hypothalamic–pituitary–adrenocortical axis), appetite, anxiety, and cardiovascular functions—providing protection against ischemic injury in heart tissue[1][10]. It also modulates cell proliferation through signaling pathways like ERK1/2 (MAPK cascade), in a tissue- and receptor-dependent manner, and may play roles in various diseases such as heart failure, obesity, depression, and inflammatory disorders[3][10].\n—\n**Notes on correctness:**\n- "Urocortin" itself is a neuropeptide ligand, not a classic therapeutic target such as a receptor, enzyme, or transporter.\n- The main therapeutic targets associated with urocortin are its receptors, especially the corticotropin-releasing factor receptor 2 (CRF2 receptor)[1][8].\n- If the intent was to refer to a therapeutic target suitable for drug discovery, "CRF type 2 receptor" (CRF2) would be the appropriate structured entity rather than "urocortin" itself.\n- Therefore, is_target is marked as false and is_incorrect as true for drug targeting purposes.\n\nIf you need structured information on the true drug target ("Corticotropin-releasing factor receptor 2"), please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urocortin (UCN).